We are live on
!
Find out more
SMH
Sanders Morris Harris Portfolio holdings
AUM
$172M
1-Year Est. Return
22.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.12%
1 Year Est. Return
+22.54%
3 Year Est. Return
+83.06%
5 Year Est. Return
+84.26%
10 Year Est. Return
+262.54%
AUM
$368M
AUM Growth
+$162M
(+79%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
40.47%
Top 10 Holdings %
Top 10 Hldgs %
37.21%
Holding
282
New
153
Increased
65
Reduced
25
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
uniQure
QURE
|
+$6.07M |
| 2 |
Visa
V
|
+$4.34M |
| 3 |
Elanco Animal Health
ELAN
|
+$4.18M |
| 4 |
JPMorgan Chase
JPM
|
+$4.08M |
| 5 |
Philip Morris
PM
|
+$4.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$8.99M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.68M |
| 3 |
Acushnet Holdings
GOLF
|
+$1.74M |
| 4 |
TELA Bio
TELA
|
+$1.42M |
| 5 |
Nike
NKE
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.78% |
| 2 | Technology | 16.46% |
| 3 | Financials | 16.07% |
| 4 | Communication Services | 7.17% |
| 5 | Energy | 6.5% |
Similar funds
GWCM
PWM
TA
CRFG
PSC
BAM
RPSM
BIA
Sanders Morris Harris's Q3 2020 Portfolio in Review
As of Q3 2020, Sanders Morris Harris held 282 positions worth $368M, up 79% from $206M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sanders Morris Harris deployed $149M of net new capital in Q3 2020, opening 153 new positions and adding to 65 existing holdings. Its largest new stake was uniQure: 148,267 shares worth $5.41M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was TELA Bio, an estimated $1.42M trimmed.
- Sanders Morris Harris's largest Q3 2020 buy was uniQure: 148,267 shares worth $5.41M.
- Sanders Morris Harris added most to Visa in Q3 2020, an estimated $4.34M increase.
- Sanders Morris Harris's biggest Q3 2020 reduction was TELA Bio, cutting an estimated $1.42M.
- Sanders Morris Harris fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $8.99M.
- Sanders Morris Harris's ten largest holdings make up 37% of its $368M portfolio in Q3 2020.
- Sanders Morris Harris opened 153 new positions and closed 8 in Q3 2020.
- Sanders Morris Harris's portfolio value rose 79% quarter-over-quarter to $368M.
Based on Sanders Morris Harris's 13F filing for Q3 2020, filed 16 Oct 2020.